ARG55614

anti-ATP5H antibody

anti-ATP5H antibody for Flow cytometry,IHC-Formalin-fixed paraffin-embedded sections,Western blot and Human

Controls and Markers antibody; Metabolism antibody; Signaling Transduction antibody

Overview

Product Description Rabbit Polyclonal antibody recognizes ATP5H
Tested Reactivity Hu
Predict Reactivity Bov
Tested Application FACS, IHC-P, WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name ATP5H
Antigen Species Human
Immunogen KLH-conjugated synthetic peptide corresponding to aa. 68-97 (Center) of Human ATP5H.
Conjugation Un-conjugated
Alternate Names ATPQ; ATP synthase subunit d, mitochondrial; ATPase subunit d

Application Instructions

Application Suggestion
Tested Application Dilution
FACS1:10 - 1:50
IHC-P1:50 - 1:100
WB1:1000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control HepG2

Properties

Form Liquid
Purification Purification with Protein A and immunogen peptide.
Buffer PBS and 0.09% (W/V) Sodium azide
Preservative 0.09% (W/V) Sodium azide
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 10476 Human ATP5H

Swiss-port # O75947 Human ATP synthase subunit d, mitochondrial

Gene Symbol ATP5H
Gene Full Name ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d
Background Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. It is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, which comprises the proton channel. The F1 complex consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled in a ratio of 3 alpha, 3 beta, and a single representative of the other 3. The Fo seems to have nine subunits (a, b, c, d, e, f, g, F6 and 8). This gene encodes the d subunit of the Fo complex. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. In addition, three pseudogenes are located on chromosomes 9, 12 and 15. [provided by RefSeq, Jun 2010]
Function Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements. [UniProt]
Cellular Localization Mitochondrion. Mitochondrion inner membrane.
Research Area Controls and Markers antibody; Metabolism antibody; Signaling Transduction antibody
Calculated MW 18 kDa

Images (3) Click the Picture to Zoom In

  • ARG55614 anti-ATP5H antibody IHC-P image

    Immunohistochemistry: Formalin-fixed and paraffin-embedded Human brain tissue stained with ARG55614 anti-ATP5H antibody.

  • ARG55614 anti-ATP5H antibody WB image

    Western blot: 35 µg of HepG2 cell lysate stained with ARG55614 anti-ATP5H antibody.

  • ARG55614 anti-ATP5H antibody FACS image

    Flow Cytometry: HepG2 cells stained with ARG55614 anti-ATP5H antibody (right histogram) or without primary antibody as control (left histogram), followed by incubation with FITC labelled secondary antibody.